1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )TABLE 1:Baseline characteristics
Characteristic Device Group (n = 475) Manual-Compression Group (n = 79) P Value Male/Female 197 (41)/278 (59) 30 (38)/49 (62) >.05 Age (years)a 58.8 ± 14.4 50.1 ± 17.0 <.0001 Diabetes 108 (23) 3 (3.8) <.0001 Coronary artery disease 84 (18) 10 (13) >.05 TIA/CVA 184 (39) 8 (10) <.0001 Preprocedural drug Heparin 104 (22) 5 (6.3) .0013 Abciximab 14 (2.9) 0 >.05 Aspirin/clopidogrel 268 (56) 12 (15) <.0001 Previous device procedures 0 337 (71) 54 (68) >.05 1 90 (19) 15 (19) >.05 2 34 (7.2) 8 (10) >.05 3 9 (1.9) 1 (1.3) >.05 4 4 (0.8) 0 >.05 5 1 (0.2) 1 (1.3) >.05
Note.—Data in parentheses are percentages.
a Mean ± standard deviation.